◆ 会议时间：2027年6月10-12日
◆ 会议地点：比利时 布鲁塞尔

◆ 会议简介：

2027年国际卫生技术评估协会(HTAi)年会将于2027年6月10-12日在比利时布鲁塞尔举行。

国际卫生技术评估协会(HTAi)是一个是全球性的、非营利性科学与专业学会，代表来自全球65个国家的82个组织和2500多名个人成员，他们是卫生技术评估研究人员、机构、政策制定者、消费者/患者、学术界和企业界人士。HTAi的任务是是通过提供一个中立的全球论坛，以交流信息、方法和专业知识，来支持HTA社区的发展，领域国际医学会议网译。HTAi主要借助循证医学、临床流行病学与卫生经济学宣等原理和方法，综合系统评价卫生技术的安全性、有效性、经济性、社会伦理和法律适应性等提出应用与否的建议，供决策者和机构参考。

HTAi每年定期在不同国家举办学术交流会议以促进全球HTA的发展。第一届HTAi年会于2003年在加拿大阿尔伯塔省坎莫尔举行，此后于每年的5月、6月或7月举行。HTAi年会汇集了来自世界各地的1,000多名研究人员、政策制定者、工业界、学术界、医疗服务提供者、机构和患者/消费者，是分享最新研究，推进政策和方法讨论以及围绕HTA建立全球网络的重要国际会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

HTAi 2027 - Health Technology Assessment international (HTAi) Annual Meeting

Date:
June 12–16, 2027

Venue:
Brussels, Belgium

Health Technology Assessment International (HTAi) is pleased to announce that its 2027 Annual Meeting will take place in Brussels, Belgium, from June 12–16, 2027.

Hosted in partnership with the Belgium Health Care Knowledge Centre (KCE) and the National Institute for Health and Disability Insurance (RIZIV/INAMI), with support from the Brussels Center for Collaboration in Health (BCCH), the meeting will bring together the global health technology assessment (HTA) community at a pivotal moment for health systems worldwide.

Under the theme “HTA in a Time of Transformation,” the Annual Meeting will explore how HTA can continue to support evidence-informed decision-making amid rapid technological advancement, evolving health system priorities, growing demands for sustainability, and changing expectations around the use of data and innovation. The program will foster discussion on the opportunities and challenges shaping the future of HTA and the role it can play in strengthening health systems and improving outcomes for patients and populations.

Held annually each June, the HTAi Annual Meeting is the premier international forum for advancing the science, practice, and impact of health technology assessment. Over five days, participants engage in scientific presentations, workshops, panel discussions, networking opportunities, and collaborative learning experiences designed to strengthen evidence-informed healthcare decision-making around the world.

◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从事该领域研究的专家、科研人员、医药企业等。